Milestone Gross Profit from 2010 to 2024

MIST Stock

USD 1.84 0.01 0.54%

Milestone Pharmaceuticals Gross Profit yearly trend continues to be comparatively stable with very little volatility. Gross Profit will likely drop to about 381.9 K in 2024. Gross Profit is the profit Milestone Pharmaceuticals makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2010-12-31

Previous Quarter

402 K

Current Value

381.9 K

Quarterly Volatility

4 M

Credit Downgrade

Yuan Drop

Covid

Check Milestone Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Milestone Pharmaceuticals' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 1.2 M or Interest Income of 3.7 M, as well as many indicators such as Price To Sales Ratio of 75.32, Dividend Yield of 0.0 or PTB Ratio of 4.49. Milestone financial statements analysis is a perfect complement when working with Milestone Pharmaceuticals Valuation or Volatility modules.

Check out the analysis of Milestone Pharmaceuticals Correlation against competitors.

For more information on how to buy Milestone Stock please use our How to Invest in Milestone Pharmaceuticals guide.

Latest Milestone Pharmaceuticals' Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Milestone Pharmaceuticals over the last few years. Gross profit is a required income statement account that reflects total revenue of Milestone Pharmaceuticals minus its cost of goods sold. It is profit before Milestone Pharmaceuticals operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Milestone Pharmaceuticals' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Milestone Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 5 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

Milestone Gross Profit Regression Statistics

	Arithmetic Mean	1,344,793
	Geometric Mean	0.00
	Coefficient Of Variation	297.03
	Mean Deviation	2,308,055
	Median	0.00
	Standard Deviation	3,994,438
	Sample Variance	16T
	Range	15.4M
	R-Value	0.35
	Mean Square Error	15T
	R-Squared	0.13
	Significance	0.20
	Slope	316,019
	Total Sum of Squares	223.4T

Milestone Gross Profit History

	2024	381.9 K
	2023	402 K
	2022	5 M
	2021	15 M
	2020	-376 K
	2019	-236 K

Other Fundumenentals of Milestone Pharmaceuticals

Gross Profit Margin

Milestone Pharmaceuticals Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Short Term Investments	Capital Surpluse	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Common Stock	Property Plant Equipment	Capital Stock
Total Assets		0.86	0.88	-0.56	-0.63	0.96	0.33	0.57	0.58	-0.48	0.89	1.0	1.0	0.83	0.49	0.83
Total Stockholder Equity	0.86		0.96	-0.54	-0.57	0.84	0.14	0.68	0.53	-0.82	0.97	0.86	0.86	0.88	0.42	0.86
Net Tangible Assets	0.88	0.96		-0.36	-0.74	0.91	0.4	0.73	0.7	-0.79	1.0	0.88	0.87	0.95	0.61	0.95
Net Debt	-0.56	-0.54	-0.36		-0.18	-0.45	0.52	-0.03	0.19	0.16	-0.38	-0.57	-0.58	-0.21	0.39	-0.18
Retained Earnings	-0.63	-0.57	-0.74	-0.18		-0.74	-0.82	-0.54	-0.98	0.48	-0.73	-0.62	-0.6	-0.88	-0.93	-0.9
Accounts Payable	0.96	0.84	0.91	-0.45	-0.74		0.48	0.59	0.68	-0.48	0.91	0.96	0.95	0.88	0.59	0.89
Net Receivables	0.33	0.14	0.4	0.52	-0.82	0.48		0.41	0.77	-0.13	0.38	0.32	0.3	0.53	0.88	0.57
Short Term Investments	0.57	0.68	0.73	-0.03	-0.54	0.59	0.41		0.39	-0.62	0.73	0.56	0.55	0.72	0.67	0.71
Capital Surpluse	0.58	0.53	0.7	0.19	-0.98	0.68	0.77	0.39		-0.48	0.69	0.57	0.55	0.84	0.87	0.86
Total Liab	-0.48	-0.82	-0.79	0.16	0.48	-0.48	-0.13	-0.62	-0.48		-0.8	-0.48	-0.47	-0.71	-0.4	-0.71
Net Invested Capital	0.89	0.97	1.0	-0.38	-0.73	0.91	0.38	0.73	0.69	-0.8		0.88	0.88	0.95	0.6	0.94
Total Current Assets	1.0	0.86	0.88	-0.57	-0.62	0.96	0.32	0.56	0.57	-0.48	0.88		1.0	0.82	0.47	0.82
Net Working Capital	1.0	0.86	0.87	-0.58	-0.6	0.95	0.3	0.55	0.55	-0.47	0.88	1.0		0.8	0.46	0.81
Common Stock	0.83	0.88	0.95	-0.21	-0.88	0.88	0.53	0.72	0.84	-0.71	0.95	0.82	0.8		0.77	1.0
Property Plant Equipment	0.49	0.42	0.61	0.39	-0.93	0.59	0.88	0.67	0.87	-0.4	0.6	0.47	0.46	0.77		0.79
Capital Stock	0.83	0.86	0.95	-0.18	-0.9	0.89	0.57	0.71	0.86	-0.71	0.94	0.82	0.81	1.0	0.79

Click cells to compare fundamentals

About Milestone Pharmaceuticals Financial Statements

Milestone Pharmaceuticals shareholders use historical fundamental indicators, such as Gross Profit, to determine how well the company is positioned to perform in the future. Although Milestone Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Milestone Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Milestone Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Gross Profit	402 K	381.9 K
Gross Profit Margin	0.40	0.72

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Milestone Stock Analysis

When running Milestone Pharmaceuticals' price analysis, check to measure Milestone Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Pharmaceuticals is operating at the current time. Most of Milestone Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Milestone Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Pharmaceuticals' price. Additionally, you may evaluate how the addition of Milestone Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC